True North Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,421
| Closed | -$305K | – | 221 |
|
2023
Q4 | $305K | Buy |
+3,421
| New | +$305K | 0.08% | 137 |
|
2021
Q3 | – | Sell |
-1,530
| Closed | -$207K | – | 228 |
|
2021
Q2 | $207K | Hold |
1,530
| – | – | 0.04% | 211 |
|
2021
Q1 | $207K | Hold |
1,530
| – | – | 0.05% | 195 |
|
2020
Q4 | $215K | Buy |
+1,530
| New | +$215K | 0.06% | 180 |
|